AMRX
Price
$8.00
Change
-$0.07 (-0.87%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
1.87B
11 days until earnings call
HROW
Price
$37.23
Change
+$0.29 (+0.78%)
Updated
Jul 24 closing price
Capitalization
467.85M
18 days until earnings call
Interact to see
Advertisement

AMRX vs HROW

Header iconAMRX vs HROW Comparison
Open Charts AMRX vs HROWBanner chart's image
Amneal Pharmaceuticals
Price$8.00
Change-$0.07 (-0.87%)
Volume$27.5K
Capitalization1.87B
Harrow
Price$37.23
Change+$0.29 (+0.78%)
Volume$302.39K
Capitalization467.85M
AMRX vs HROW Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. HROW commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and HROW is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (AMRX: $8.00 vs. HROW: $37.24)
Brand notoriety: AMRX and HROW are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 48% vs. HROW: 73%
Market capitalization -- AMRX: $1.87B vs. HROW: $467.85M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. HROW’s [@Pharmaceuticals: Other] market capitalization is $467.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • HROW’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • HROW’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRX and HROW are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -2.91% price change this week, while HROW (@Pharmaceuticals: Other) price change was +3.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.61%. For the same industry, the average monthly price growth was +12.25%, and the average quarterly price growth was +74.93%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

HROW is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than HROW($468M). AMRX has higher P/E ratio than HROW: AMRX (90.00) vs HROW (39.53). HROW YTD gains are higher at: 10.984 vs. AMRX (1.010). AMRX has higher annual earnings (EBITDA): 400M vs. HROW (9.95M). AMRX has more cash in the bank: 91.5M vs. HROW (82.8M). HROW has less debt than AMRX: HROW (191M) vs AMRX (2.75B). AMRX has higher revenues than HROW: AMRX (2.39B) vs HROW (130M).
AMRXHROWAMRX / HROW
Capitalization1.87B468M400%
EBITDA400M9.95M4,018%
Gain YTD1.01010.9849%
P/E Ratio90.0039.53228%
Revenue2.39B130M1,842%
Total Cash91.5M82.8M111%
Total Debt2.75B191M1,440%
FUNDAMENTALS RATINGS
AMRX vs HROW: Fundamental Ratings
AMRX
HROW
OUTLOOK RATING
1..100
6713
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
6246
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
5640
P/E GROWTH RATING
1..100
2611
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (78) in the Pharmaceuticals Other industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is in the same range as AMRX (62) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as AMRX (56) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as AMRX (26) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXHROW
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGPX20.700.04
+0.19%
NYLI PineStone Global Equity Class P
MNDJX29.71N/A
N/A
MFS New Discovery R4
FSCSX28.98N/A
N/A
Fidelity Select Software & IT Svcs Port
TLOTX9.74N/A
N/A
Transamerica Large Value Opps I3
ARBFX13.50-0.01
-0.07%
Arbitrage R

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-0.87%
PAHC - AMRX
47%
Loosely correlated
-1.17%
HROW - AMRX
46%
Loosely correlated
+0.77%
VTRS - AMRX
43%
Loosely correlated
-0.21%
ZTS - AMRX
39%
Loosely correlated
-0.41%
AMPH - AMRX
39%
Loosely correlated
-0.53%
More